Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide

Shih Chung Chen, Yu Chi Liu, Kou Gi Shyu, Danny Ling Wang

研究成果: 雜誌貢獻文章

30 引文 (Scopus)

摘要

Endothelial cells (ECs) play an important role in hypoxia-induced vascular disorders. We investigated the acute hypoxia effect on endothelial expression of activating transcription factor 3 (ATF3), a stress-inducible transcription factor playing significant roles in cellular responses to stress. Bovine aortic ECs were subjected to acute hypoxia (1% O2, pO2 = 8 mmHg) and ATF3 expression was examined. ECs exposed to hypoxia transiently induced ATF3 expression. A transient increase in the activation of c-Jun-NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in ECs was observed; however, only ECs pretreated with a specific inhibitor to JNK suppressed the hypoxia-induced ATF3 expression. ECs exposed to acute hypoxia transiently increased endothelial nitric oxide (eNOS) activity. Pre-treating ECs with a specific inhibitor to eNOS (l-NAME) or PI3-kinase significantly inhibited the hypoxia-induced JNK activation and ATF3 expression. ATF3 induction has been shown to inhibit matrix metalloproteinase-2 (MMP-2) expression. Consistently, ECs exposed to hypoxia attenuated the MMP-2 expression. This hypoxia-attenuated MMP-2 expression can be rescued by pre-treating ECs with an inhibitor of eNOS. These results suggest that the ATF3 induction by acute hypoxia is mediated by nitric oxide and the JNK pathway in ECs. Our findings provide a molecular basis for the mechanism in which ECs respond to acute hypoxia.
原文英語
頁(從 - 到)281-288
頁數8
期刊Atherosclerosis
201
發行號2
DOIs
出版狀態已發佈 - 十二月 2008

指紋

Activating Transcription Factor 3
Nitric Oxide
Endothelial Cells
JNK Mitogen-Activated Protein Kinases
Matrix Metalloproteinase 2
Hypoxia
p38 Mitogen-Activated Protein Kinases
Phosphatidylinositol 3-Kinases
Blood Vessels

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

引用此文

Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. / Chen, Shih Chung; Liu, Yu Chi; Shyu, Kou Gi; Wang, Danny Ling.

於: Atherosclerosis, 卷 201, 編號 2, 12.2008, p. 281-288.

研究成果: 雜誌貢獻文章

Chen, Shih Chung ; Liu, Yu Chi ; Shyu, Kou Gi ; Wang, Danny Ling. / Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide. 於: Atherosclerosis. 2008 ; 卷 201, 編號 2. 頁 281-288.
@article{f254cbb4d7134010b2a535b6001bb976,
title = "Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide",
abstract = "Endothelial cells (ECs) play an important role in hypoxia-induced vascular disorders. We investigated the acute hypoxia effect on endothelial expression of activating transcription factor 3 (ATF3), a stress-inducible transcription factor playing significant roles in cellular responses to stress. Bovine aortic ECs were subjected to acute hypoxia (1{\%} O2, pO2 = 8 mmHg) and ATF3 expression was examined. ECs exposed to hypoxia transiently induced ATF3 expression. A transient increase in the activation of c-Jun-NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in ECs was observed; however, only ECs pretreated with a specific inhibitor to JNK suppressed the hypoxia-induced ATF3 expression. ECs exposed to acute hypoxia transiently increased endothelial nitric oxide (eNOS) activity. Pre-treating ECs with a specific inhibitor to eNOS (l-NAME) or PI3-kinase significantly inhibited the hypoxia-induced JNK activation and ATF3 expression. ATF3 induction has been shown to inhibit matrix metalloproteinase-2 (MMP-2) expression. Consistently, ECs exposed to hypoxia attenuated the MMP-2 expression. This hypoxia-attenuated MMP-2 expression can be rescued by pre-treating ECs with an inhibitor of eNOS. These results suggest that the ATF3 induction by acute hypoxia is mediated by nitric oxide and the JNK pathway in ECs. Our findings provide a molecular basis for the mechanism in which ECs respond to acute hypoxia.",
keywords = "Activating transcription factor 3, Hypoxia, Matrix metalloproteinase-2, Mitogen-activated protein kinase, Nitric oxide, Reactive oxygen species",
author = "Chen, {Shih Chung} and Liu, {Yu Chi} and Shyu, {Kou Gi} and Wang, {Danny Ling}",
year = "2008",
month = "12",
doi = "10.1016/j.atherosclerosis.2008.02.014",
language = "English",
volume = "201",
pages = "281--288",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Acute hypoxia to endothelial cells induces activating transcription factor 3 (ATF3) expression that is mediated via nitric oxide

AU - Chen, Shih Chung

AU - Liu, Yu Chi

AU - Shyu, Kou Gi

AU - Wang, Danny Ling

PY - 2008/12

Y1 - 2008/12

N2 - Endothelial cells (ECs) play an important role in hypoxia-induced vascular disorders. We investigated the acute hypoxia effect on endothelial expression of activating transcription factor 3 (ATF3), a stress-inducible transcription factor playing significant roles in cellular responses to stress. Bovine aortic ECs were subjected to acute hypoxia (1% O2, pO2 = 8 mmHg) and ATF3 expression was examined. ECs exposed to hypoxia transiently induced ATF3 expression. A transient increase in the activation of c-Jun-NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in ECs was observed; however, only ECs pretreated with a specific inhibitor to JNK suppressed the hypoxia-induced ATF3 expression. ECs exposed to acute hypoxia transiently increased endothelial nitric oxide (eNOS) activity. Pre-treating ECs with a specific inhibitor to eNOS (l-NAME) or PI3-kinase significantly inhibited the hypoxia-induced JNK activation and ATF3 expression. ATF3 induction has been shown to inhibit matrix metalloproteinase-2 (MMP-2) expression. Consistently, ECs exposed to hypoxia attenuated the MMP-2 expression. This hypoxia-attenuated MMP-2 expression can be rescued by pre-treating ECs with an inhibitor of eNOS. These results suggest that the ATF3 induction by acute hypoxia is mediated by nitric oxide and the JNK pathway in ECs. Our findings provide a molecular basis for the mechanism in which ECs respond to acute hypoxia.

AB - Endothelial cells (ECs) play an important role in hypoxia-induced vascular disorders. We investigated the acute hypoxia effect on endothelial expression of activating transcription factor 3 (ATF3), a stress-inducible transcription factor playing significant roles in cellular responses to stress. Bovine aortic ECs were subjected to acute hypoxia (1% O2, pO2 = 8 mmHg) and ATF3 expression was examined. ECs exposed to hypoxia transiently induced ATF3 expression. A transient increase in the activation of c-Jun-NH2-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) in ECs was observed; however, only ECs pretreated with a specific inhibitor to JNK suppressed the hypoxia-induced ATF3 expression. ECs exposed to acute hypoxia transiently increased endothelial nitric oxide (eNOS) activity. Pre-treating ECs with a specific inhibitor to eNOS (l-NAME) or PI3-kinase significantly inhibited the hypoxia-induced JNK activation and ATF3 expression. ATF3 induction has been shown to inhibit matrix metalloproteinase-2 (MMP-2) expression. Consistently, ECs exposed to hypoxia attenuated the MMP-2 expression. This hypoxia-attenuated MMP-2 expression can be rescued by pre-treating ECs with an inhibitor of eNOS. These results suggest that the ATF3 induction by acute hypoxia is mediated by nitric oxide and the JNK pathway in ECs. Our findings provide a molecular basis for the mechanism in which ECs respond to acute hypoxia.

KW - Activating transcription factor 3

KW - Hypoxia

KW - Matrix metalloproteinase-2

KW - Mitogen-activated protein kinase

KW - Nitric oxide

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=56649119180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56649119180&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2008.02.014

DO - 10.1016/j.atherosclerosis.2008.02.014

M3 - Article

C2 - 18377912

AN - SCOPUS:56649119180

VL - 201

SP - 281

EP - 288

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -